Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS clinical trials group protocol P1021

Ross E. McKinney, John Rodman, Chengcheng Hu, Paula Britto, Michael Hughes, Mary Elizabeth Smith, Leslie K. Serchuck, Joyce Kraimer, Alberto A. Ortiz, Patricia Flynn, Ram Yogev, Stephen Spector, Linda Draper, Paul Tran, Melissa Scites, Ruth Dickover, Adriana Weinberg, Coleen Cunningham, Elaine Abrams, M. Robert BlumGregory E. Chittick, Laurie Reynolds, Mobeen Rathore

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS clinical trials group protocol P1021'. Together they form a unique fingerprint.

Medicine & Life Sciences